Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
06/2012
06/07/2012US20120141560 Tumor and infectious disease therapeutic compositions
06/07/2012US20120141538 Modulators of the cx3cri receptor and therapeutic uses thereof
06/07/2012US20120141536 Use of an adjuvanted allergy vaccine formulation for parenteral administration
06/07/2012US20120141535 Process and composition for treatment of canine and human leishmaniasis
06/07/2012US20120141534 Vault Compositions for Immunization Against Chlamydia Genital Infection
06/07/2012US20120141532 Botulinum Toxin Formulation
06/07/2012US20120141531 Composition comprising oil drops
06/07/2012US20120141530 Canine lyme disease vaccine
06/07/2012US20120141529 Norovirus and sapovirus antigens
06/07/2012US20120141528 Lyophilized viral formulations
06/07/2012US20120141527 Structured viral peptide compositions and methods of use
06/07/2012US20120141526 Nanoemulsion vaccines
06/07/2012US20120141525 Universal influenza vaccine based on recombinant modified vaccine ankara virus (mva)
06/07/2012US20120141523 Immunogenic composition comprising antigenic s. aureus proteins
06/07/2012US20120141522 Recombinant protective protein from streptococcus pneumoniae
06/07/2012US20120141521 Immunogenic Compositions for Streptococcus agalactiae
06/07/2012US20120141520 Recombinant subunit west nile virus vaccine for protection of human subjects
06/07/2012US20120141519 Reagents and methods for detecting influenza virus proteins
06/07/2012US20120141518 Human Parvovirus: Bocavirus
06/07/2012US20120141517 Novel immunotherapy against several tumors including neuronal and brain tumors
06/07/2012US20120141516 Compositions and methods for inducing an immune response
06/07/2012US20120141515 Ig-pCONSENSUS GENE VACCINATION PROTECTS FROM ANTIBODY-DEPENDENT IMMUNE PATHOLOGY IN AUTOIMMUNE DISEASE
06/07/2012US20120141513 Deuterated fingolimod
06/07/2012US20120141512 Method of increasing immunological effect
06/07/2012US20120141511 Clostridial toxin derivatives able to modify peripheral sensory afferent functions
06/07/2012US20120141510 Monomethylvaline compounds capable of conjugation to ligands
06/07/2012US20120141509 Monomethylvaline compounds capable of conjugation to ligands
06/07/2012US20120141508 Monomethylvaline compounds capable of conjugation to ligands
06/07/2012US20120141507 Targeting of glycoprotein therapeutics
06/07/2012US20120141506 Treatment of non-proliferative cystic disease
06/07/2012US20120141505 Cd19-ligand and use
06/07/2012US20120141504 Methods for treating inflammation using b7-h4 polypeptides and fragments thereof
06/07/2012US20120141503 Heavy Chain and Domain Antibodies
06/07/2012US20120141502 Antibodies specific to e6 proteins of hpv and use thereof
06/07/2012US20120141501 Pharmaceutical Composition Containing Antagonist of EGF Family Ligand as Component
06/07/2012US20120141500 Antibodies Against Human Angiopoietin 2
06/07/2012US20120141499 Specific binding agents of human angiopoietin-2
06/07/2012US20120141498 Use of pkc isozymes for diagnosis and treatment of neuroblastoma
06/07/2012US20120141497 Methods of purifying small modular immunopharmaceutical proteins
06/07/2012US20120141496 Iap bir domain binding compounds
06/07/2012US20120141495 Method for suppressing tumor growth by blocking fibroblast growth factor receptor, and method for diagnosing malignant neoplasms
06/07/2012US20120141494 Fully human antibodies against human 4-1bb
06/07/2012US20120141493 Human binding molecules having killing activity against staphylococci and uses thereof
06/07/2012US20120141492 Anti-il 17a /il-17f cross-reactive antibodies and methods of use thereof
06/07/2012US20120141491 Methods and compositions for the treatment of cancers and pathogenic infections
06/07/2012US20120141490 Antibodies That Bind Selectively To P25 And Uses Therefor
06/07/2012US20120141489 Hypoxia Induced Mitogenic Factor
06/07/2012US20120141488 Novel g protein coupled receptor protein and use thereof
06/07/2012US20120141487 Moraxella catarrhalis antigens
06/07/2012US20120141486 Human monoclonal antibody
06/07/2012US20120141485 Methods of preventing or treating pain using anti-ngf antibodies
06/07/2012US20120141484 Methods of preventing inflammation and treating pain using anti-ngf compositions
06/07/2012US20120141483 Methods of treating or preventing psoriasis, and/or alzheimer's disease using indane acetic acid derivatives
06/07/2012US20120141482 Molecular complexes which modify immune responses
06/07/2012US20120141481 Wnt antagonists and their use in the diagnosis and treatment of wnt-mediated disorders
06/07/2012US20120141480 Methods of treating with anti-factor d antibodies
06/07/2012US20120141479 Histone Deacetylase Inhibitors Sensitize Cancer Cells To Epidermal Growth Factor Inhibitors
06/07/2012US20120141478 Compositions and methods for delivering anti-activated ras antibodies
06/07/2012US20120141477 Antibodies That Specifically Bind to ABeta Oligomers and Uses Thereof
06/07/2012US20120141476 FcGammaRIIB Specific Antibodies and Methods of Use Thereof
06/07/2012US20120141475 TNF-alpha Antagonists and Methotrexate in the Treatment of TNF-Mediated Disease
06/07/2012US20120141474 TNF-alpha Antagonists and Methotrexate in the Treatment of TNF-Mediated Disease
06/07/2012US20120141473 Compositions and methods for treating osteolytic disorders comprising mmp-14 binding proteins
06/07/2012US20120141472 Methods of scoring gene copy number in a biological sample using in situ hybridization
06/07/2012US20120141471 Methods of Inhibiting Metastasis from Cancer
06/07/2012US20120141470 T cell inhibitory receptor compositions and uses thereof
06/07/2012US20120141469 Cripto antagonism of activin and tgf-b signaling
06/07/2012US20120141468 Maintenance of platelet inhibition during antiplatelet therapy
06/07/2012US20120141467 Ascorbic acid to treat chronic obstructive lung diseases and non-Hodgkin's lymphoma
06/07/2012US20120141466 Composition and method for treatment of reperfusion injury and tissue damage
06/07/2012US20120141465 Virus vaccination and treatment methods with ox40 agonist compositions
06/07/2012US20120141464 Binding member for gm-csf receptor
06/07/2012US20120141463 Method Of Identifying Membrane Ig Specific Antibodies And Use Thereof For Targeting Immunoglobulin-Producing Precursor Cells
06/07/2012US20120141462 Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia
06/07/2012US20120141461 Compositions and methods for diagnosing and treating fibrotic disorders
06/07/2012US20120141460 Method for the production of variable domains
06/07/2012US20120141459 Molecular targets for als and related disorders
06/07/2012US20120141458 Compositions and methods for treatment in broad-spectrum, undifferentiated or mixed clinical applications
06/07/2012US20120141457 Lateral Flow Immunoassay for Complement Activation and Methods of Use for Point-of-Care Assessment of Complement-Associated Disorders
06/07/2012US20120141456 Use of DR6 and p75 Antagonists to Promote Survival of Cells of the Nervous System
06/07/2012US20120141449 Albumin Fusion Proteins
06/07/2012US20120141415 Albumin Fusion Proteins
06/07/2012US20120141411 Uses of IL-174 Antagonists for Inhibiting A Th2 Immune Response
06/07/2012US20120141380 Polymer nanoparticles coated by magnetic metal oxide and uses thereof
06/07/2012US20120141379 Microspheres for active embolization
06/07/2012US20120141376 Prostate specific transcripts and the use thereof for prostate cancer therapeutics and diagnostics
06/07/2012US20120141374 Methods and compositions for targeting hepsin
06/07/2012US20120141373 Antibodies and Methods of Use Thereof
06/07/2012US20120141372 RS7 Antibodies
06/07/2012US20120141371 Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility
06/07/2012CA2856697A1 Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
06/07/2012CA2821515A1 Anti-ngf compositions and use thereof
06/07/2012CA2820622A1 Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors and uses thereof
06/07/2012CA2819758A1 Composition for immunization against streptococcus pneumoniae
06/07/2012CA2819679A1 Compositions and methods for treating amyloid plaque associated symptoms
06/07/2012CA2819669A1 Chemical and rnai suppressors of neurotoxicity in huntington's disease
06/07/2012CA2819530A1 Cytotoxicity-inducing therapeutic agent
06/07/2012CA2819504A1 Anti-bradykinin b2 receptor (bkb2r) monoclonal antibody
06/07/2012CA2819463A1 Tomm34 peptides and vaccines including the same
06/07/2012CA2819429A1 Hypoallergenic polypeptides for the treatment of house dust mite allergy
1 ... 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 ... 1823